Skip to main content

Advertisement

SpringerLink
Log in

Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Regulatory subsets of B cells (Bregs) modulate immune responses in autoimmunity, cancer, and other inflammation diseases. In the present study, we investigated the numbers of circulating Breg cells in patients with rheumatoid arthritis (RA). We evaluated 59 RA patients and 25 healthy controls. CD19+CD5+CD1dhi B cells and granzyme B-secreting B cells (CD19+CD5+GzmB+) were analyzed by flow cytometry in peripheral blood mononuclear cells. We detected serum interleukin 10 (IL-10), interleukin 21 (IL-21), granzyme B (GzmB) using enzyme-linked immunosorbent assay (ELISA). Compared to control subjects, we found a decreased proportion of CD19+CD5+CD1dhi B cells in RA patients. The number of CD19+CD5+CD1dhi B cells negatively correlated with DAS28 (P < 0.05). Moreover, serum IL-10 and IL-21 concentrations were significantly lower in RA patients compared to healthy controls (P < 0.05). Conversely, the number of CD19+CD5+GzmB+ B cells was significantly higher in RA patients (P < 0.05), and the number of CD19+CD5+GzmB+ B cells did not correlate with DAS28, IL-21, or GzmB (P > 0.05, all). Interestingly, IL-21 and GzmB levels positively correlated in RA patients (P < 0.05). Our data indicate that CD19+CD5+CD1dhi B cells influence RA disease activity. CD19+CD5+GzmB+ B cells may be involved in RA development and progression. Our data strongly suggest a role for Bregs in RA, and Bregs may be a viable therapeutic strategy for RA disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307–10.

    Article  CAS  PubMed  Google Scholar 

  2. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.

    Article  CAS  PubMed  Google Scholar 

  3. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–108.

    Article  PubMed  Google Scholar 

  4. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705–10.

    Article  CAS  PubMed  Google Scholar 

  5. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10 competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Flores-Borja F, Bosma A, Mauri C, et al. CD19 + CD24hiCD38hi B cells Maintain Regulatory T Cells While Limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;V5N173:173ra23.

  7. Lee JH, Noh J, Noh G, et al. Allergen-specific transforming growth factor-β-producing CD19(+)CD5(+)regulatory B cell(Br 3) responses in human late eczematous allergic reactions to cow’s milk. J Interferon Cytokine Res. 2011;31:441–9.

    Article  CAS  PubMed  Google Scholar 

  8. Noh J, Choi WS, Noh S, et al. Presence of Foxp3-expressing CD19(+)CD5(+) B cells in human peripheral blood mononuclear cells: human CD19(+)CD5(+)Foxp3(+) regulatory B cell (Breg). Immune Netw. 2010;10:247–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lundy SK. Killer B lymphocytes: the evidence and the potential. Inflamm Res. 2009;58(7):345–57.

    Article  CAS  PubMed  Google Scholar 

  10. Yang M, Den J, Liu J, et al. IL-10-producing regulatory B10 cells sameliorate collagen induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012;180(6):2375–85.

    Article  CAS  PubMed  Google Scholar 

  11. Hagn M, Ebel V, Sontheimer K, et al. CD5 + B cells from individuals with systemic lupus erythematosus express granzyme B. Eur J Immunol. 2010;40(7):2060–9.

    Article  CAS  PubMed  Google Scholar 

  12. Jahrsdörfer B, Blackwell SE, Wooldridge JE, et al. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood. 2006;108(8):2712–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lindner S, Dahlke K, Sontheimer K, et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013;73(8):2468–9.

    Article  CAS  PubMed  Google Scholar 

  14. Goldbach-Mansky R, Suson S, et al. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. Ann Rheum Dis. 2005;64(5):715–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.

    Article  CAS  PubMed  Google Scholar 

  16. Prevoo ML, Van’t Hof MA, Kuper HH, et al. Modified disease activity scores that includes twenty-eight joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–8.

    Article  CAS  PubMed  Google Scholar 

  17. Kalampokis I, Yoshizaki A, Tedder TF. IL-10-producing regulatory B cells(B10 cells) in autoimmune disease. Arthritis Res Ther. 2013;15(Suppl 1):S1.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yang M, Rui K, Wang S, et al. Regulatory B cells in autoimmune diseases. Cell Mol Immunol. 2013;10(2):122–32.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221–41.

    Article  CAS  PubMed  Google Scholar 

  20. Ma L, Liu B, Jiang Z, et al. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Rheumatol. 2014;33(2):187–95.

    Article  PubMed  Google Scholar 

  21. Daien CI, Gailhac S, et al. (2014) Regulatory B10 cels are decreased in patients with rheumatoid arthritis and inversely correlated with disease activity.Arthritis Rheumatol. [Epup ahead of print].

  22. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010;1183:38–57.

    Article  CAS  PubMed  Google Scholar 

  23. Tian G, Li JL, Wang DG, et al. (2014) Targeting IL-10 in Auto-immune Diseases. Cell Biochem Biophys s12013-14-9903-x.

  24. Chen R, Tao Y, Qiu K, et al. Association of circulating Treg cells with disease activity in patients with rheumatoid arthritis. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32(6):886–9.

    CAS  PubMed  Google Scholar 

  25. Hagn M, Sontheimer K, Dahlke K, et al. Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol Cell Biol. 2012;90(4):457–67.

    Article  CAS  PubMed  Google Scholar 

  26. Ozaki K, Spolski R, Feng CG, et al. A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298:1630–4.

    Article  CAS  PubMed  Google Scholar 

  27. Konforte D, Simard N, Paige CJ. IL-21: an executor of B cell fate. J Immunol. 2009;182:1781–7.

    Article  CAS  PubMed  Google Scholar 

  28. Yoshizaki A, Miyagaki T, Tedder TF. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol. 2003;15(5):533–43.

    Article  CAS  PubMed  Google Scholar 

  30. Tak PP, Spaeny-Dekking, et al. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 1999; 116(2): 366–70.

Download references

Acknowledgments

This study was supported by Grants from the Zhejiang Province Natural Science Fund (LY12H10002). We thank Prof. Jahrsdörfer, Thamara Beyer for helpful advice.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province, Affiliated Hospital of Wenzhou Medical University, Taizhou, Zhejiang, China

    Donghua Cui, Lili Zhang, Jiaxi Chen, Min Zhu, Li Hou, Baoguo Chen & Bo Shen

Authors
  1. Donghua Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lili Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiaxi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Baoguo Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bo Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Shen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cui, D., Zhang, L., Chen, J. et al. Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity. Clin Exp Med 15, 285–292 (2015). https://doi.org/10.1007/s10238-014-0310-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-014-0310-9

Keywords

Search

Navigation